NASH Patient's Itinerary: Comparison of Strategies for Screening, Referring and Management of Diabetic Patients

NACompletedINTERVENTIONAL
Enrollment

536

Participants

Timeline

Start Date

January 31, 2021

Primary Completion Date

January 31, 2023

Study Completion Date

January 8, 2024

Conditions
Non-alcoholic Fatty Liver Disease (NAFLD)
Interventions
DIAGNOSTIC_TEST

Derivation algorithms

Derivation algorithm based on non-invasive methods, to standardise the continuum of care for diabetic patients with NAFLD from primary care and endocrinology settings to NAFLD specialised units (NSU)

Trial Locations (4)

41013

Hospital Universitario Virgen del Rocío de Sevilla, Seville

Unknown

University Hospital Düsseldorf, Düsseldorf

University Medical Center Mainz, Mainz

Harokopio University of Athens, Athens

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

collaborator

Barcelona Institute for Global Health

OTHER

collaborator

Harokopio University

OTHER

collaborator

University Medical Center Mainz

OTHER

collaborator

University Düsseldorf

OTHER

lead

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

OTHER

NCT06688149 - NASH Patient's Itinerary: Comparison of Strategies for Screening, Referring and Management of Diabetic Patients | Biotech Hunter | Biotech Hunter